4//SEC Filing
Kline Kyle 4
Accession 0001193125-26-010699
CIK 0001237831other
Filed
Jan 11, 7:00 PM ET
Accepted
Jan 12, 5:40 PM ET
Size
8.4 KB
Accession
0001193125-26-010699
Insider Transaction Report
Form 4
Kline Kyle
Senior Vice President, CFO
Transactions
- Exercise/Conversion
Class A Common Stock
2026-01-08$51.87/sh+3,594$186,421→ 3,594 total - Sale
Class A Common Stock
[F1]2026-01-08$101.10/sh−3,594$363,353→ 0 total - Exercise/Conversion
Stock Option (Right to Buy Class A Common Stock)
[F2]2026-01-08−3,594→ 3,906 totalExercise: $51.87Exp: 2034-03-14→ Class A Common Stock (3,594 underlying)
Footnotes (2)
- [F1]This sale was effectuated pursuant to a Rule 10b5-1 trading plan dated August 25, 2025 executed by the reporting person.
- [F2]These options were granted on March 14, 2024, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2025, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
Signature
/s/ Kelly G. Huller, Attorney-in-Fact|2026-01-12
Documents
Issuer
GLOBUS MEDICAL INC
CIK 0001237831
Entity typeother
Related Parties
1- filerCIK 0002080625
Filing Metadata
- Form type
- 4
- Filed
- Jan 11, 7:00 PM ET
- Accepted
- Jan 12, 5:40 PM ET
- Size
- 8.4 KB